{
    "clinical_study": {
        "@rank": "153235", 
        "arm_group": [
            {
                "arm_group_label": "Herpes Patch SOS (Hansaplast\u00ae)", 
                "arm_group_type": "Active Comparator"
            }, 
            {
                "arm_group_label": "Herpes vesicle patch of Compeed\u00ae", 
                "arm_group_type": "Active Comparator"
            }
        ], 
        "brief_summary": {
            "textblock": "Recent clinical studies showed, that a hydrocolloid patch is effective, well tolerated and\n      comparable with aciclovir cream 5 % for the treatment of HSL lesions, while affording\n      additional benefits of wound protection, discretion and relief of social embarrassment. The\n      aim of the actual study was the clinical assessment of the effectiveness and safety of\n      Hansaplast\u00ae SOS Herpes Patch (HPHP) in comparison to Compeed\u00ae Herpes Vesicle Patch (CHP) in\n      treating HSL. Both products are CE-certificated and are available at the market for medical\n      devices."
        }, 
        "brief_title": "Clinical Assessment of the Effectiveness and Safety of Herpes Patch SOS in the Treatment of Herpes Simplex Labialis in Comparison to a Competitor's Product.", 
        "completion_date": {
            "#text": "June 2010", 
            "@type": "Actual"
        }, 
        "condition": "Herpes Simplex Labialis", 
        "condition_browse": {
            "mesh_term": [
                "Herpes Labialis", 
                "Herpes Simplex"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  at least 18 years old\n\n          -  with a history of recurrent HSL of the lips and/or perioral skin\n\n          -  lesions typically manifesting as classical lesions\n\n          -  duration of HSL symptoms not more than three days\n\n          -  haven\u00b4t used acyclovir or other cold sore therapies\n\n        Exclusion Criteria:\n\n          -  pregnancy\n\n          -  lactating women\n\n          -  women of child-bearing age without medically secured contraceptions\n\n          -  topical or systemic therapy with analgesic\n\n          -  anti-inflammatory or antiviral agents within the last 2 weeks\n\n          -  topical therapy within the treatment area\n\n          -  systemic therapy with cytostatics or immunosuppressants"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "firstreceived_date": "October 28, 2010", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02157090", 
            "org_study_id": "Herpes patch study 32583"
        }, 
        "intervention": [
            {
                "arm_group_label": "Herpes Patch SOS (Hansaplast\u00ae)", 
                "intervention_name": "Herpes Patch SOS (Hansaplast\u00ae)", 
                "intervention_type": "Other"
            }, 
            {
                "arm_group_label": "Herpes vesicle patch of Compeed\u00ae", 
                "intervention_name": "Herpes vesicle patch of Compeed\u00ae", 
                "intervention_type": "Other"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "HSL of lips", 
            "perioral skin", 
            "duration of HSL symptoms not more than three days", 
            "not acyclovir or other cold sore therapies"
        ], 
        "lastchanged_date": "June 2, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Dresden", 
                    "country": "Germany", 
                    "state": "Saxony", 
                    "zip": "01307"
                }, 
                "name": "University Hospital Carl Gustav Carus at the Technische Universit\u00e4t Dresden"
            }
        }, 
        "location_countries": {
            "country": "Germany"
        }, 
        "official_title": "Clinical Assessment of the Effectiveness and Safety of Herpes Patch SOS (Hansaplast\u00ae) Based on Hydrocolloids Without Active Substances in the Treatment of Herpes Simplex Labialis in Comparison to a Competitor's Product (Herpes Vesicle Patch of COMPEED\u00ae)", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Germany: Federal Institute for Drugs and Medical Devices"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "January 2010", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "The primary endpoint of this study was the Subjects Global Assessment of Therapy (SGAT) at final visit."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02157090"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Number of patients with healed HSL lesions on day 5 and day 10 (assessed by clinician)"
            }, 
            {
                "measure": "Blinded clinician global assessment (IGAT) at the end of therapy."
            }, 
            {
                "measure": "Development of lesion size."
            }, 
            {
                "measure": "The number of study subjects with vesicles at onset of the study and at visit 2 and the final visit 3."
            }, 
            {
                "measure": "Clinician-assessed lesion stage at onset of the study and at visit 2 and the final visit 3."
            }, 
            {
                "measure": "Clinician-assessed time to complete healing from begin of the study."
            }, 
            {
                "measure": "Time to complete healing of HSL after beginning of signs and symptoms."
            }, 
            {
                "measure": "Assessment of the local compatibility by patient and by investigator."
            }, 
            {
                "measure": "The severity and duration of subject-assessed individual signs and symptoms."
            }
        ], 
        "source": "Technische Universit\u00e4t Dresden", 
        "sponsors": {
            "collaborator": {
                "agency": "Beiersdorf AG", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Technische Universit\u00e4t Dresden", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "August 2009", 
        "study_design": "N/A", 
        "study_type": "Interventional", 
        "verification_date": "June 2014"
    }
}